Literature DB >> 19016796

Crystal structures of a new polymorphic form of gabapentin monohydrate and the e and z isomers of 4-tertiarybutylgabapentin.

Prema G Vasudev1, Subrayashastry Aravinda, Kuppanna Ananda, Shettykere Dayananda Veena, Kuppuswamy Nagarajan, Narayanaswamy Shamala, Padmanabhan Balaram.   

Abstract

Gabapentin, a widely used antiepileptic drug, crystallizes in multiple polymorphic forms. A new crystal form of gabapentin monohydrate in the space group Pbca is reported and the packing arrangement compared with that of a previously reported polymorph in the space group P2(1)/c [Ibers, J.A. (2001) Acta Crystallogr; C57:641]. Gabapentin polymorphs can also occur from a selection of one of the two distinct chair forms of the 1,1-disubstituted cyclohexane. Crystal structures of the E and Z isomers of 4-tert-butylgabapentin provide models for analyzing anticipated packing modes in the conformational isomers of gabapentin. The E isomer crystallized in the space group Pca2(1), while the Z isomer crystallized in the space group P2(1)/c. The crystal structure of E-4-tert-butylgabapentin provides the only example of a structure in a non-centrosymmetric space group. Crystal structures of the hydrochloride and hydrobromide salts of 4-tert-butyl derivatives are reported. The results suggest that for gabapentin, a large 'polymorph-space' may be anticipated, in view of the multiple conformational states that are accessible to the molecule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016796     DOI: 10.1111/j.1747-0285.2008.00726.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

1.  2-(1-Amino-4-tert-butyl-cyclo-hex-yl)acetic acid (tBu-β(3,3)-Ac6c) hemihydrate.

Authors:  Naiem Ahmad Wani; Vivek K Gupta; Rajni Kant; Subrayashastry Aravinda; Rajkishor Rai
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-15

Review 2.  The Lisbon Supramolecular Green Story: Mechanochemistry towards New Forms of Pharmaceuticals.

Authors:  João Luís Ferreira da Silva; M Fátima Minas da Piedade; Vânia André; Sofia Domingos; Inês C B Martins; M Teresa Duarte
Journal:  Molecules       Date:  2020-06-11       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.